Order Inspection Copy

To order an inspection copy of this book you must be an Academic or Teacher. Please complete this form before adding to cart. To fulfill your inspection copy request, we require the following information about your position and campus.

* Required Fields

To complete your Inspection Copy Request you will need to click the Checkout button in the right margin and complete the checkout formalities. You can include Inspection Copies and purchased items in the same shopping cart, see our Inspection Copy terms for further information.

Any Questions? Please email our text Support Team on text@footprint.com.au


Email this to a friend

* ALL required Fields

Order Inspection Copy

An inspection copy has been added to your shopping cart

Juvenescence: Investing in the age of longevity

by Jim Mellon and Al Chalabi Harriman House
Pub Date:
Pbk 250 pages
AU$34.99 NZ$39.12
Product Status: In Stock Now
add to your cart
This new book by Jim Mellon and Al Chalabi is a layman's guide to longevity. It investigates the new technologies and explains how to benefit from the life extending technologies both personally and professionally. It helps readers unravel the science, offers ideas on potential investment and reveals the views of the key opinion leaders.

Jim Mellon is an investor with an interest in several industries. After studying PPE at Oxford, Jim worked in Asia and in the US for two fund management companies, GT Management and Thornton & Co, before establishing his own business in 1991. This business is now known by two names - Charlemagne Capital, recently acquired, and Regent Pacific Group, listed in Hong Kong. Jim's private investment company, The Burnbrae Group, is a substantial landlord in Germany and the Isle of Man, and owns the group Sleepwell Hotels. Jim is chairman and major shareholder of Manx Financial Group, Port Erin Biopharma Invesments and SalvaRx Group. He is also a director of Condor Gold, Fast Forward Innovations, Portage Biotech and West African Minerals Corporation, all publicly listed companies. Amongst his many successes, Jim is well known for notching up one of the AIM market's biggest successes with the sale of Uramin to Areva, the French nuclear giant.


Al Chalabi is an entrepreneur and business advisor with a diverse professional background. He grew up in the UK and studied Aeronautical Engineering at the University of Southampton. Al started his career in Canada, working as an engineer in process automation systems. After his MBA, he worked as a management consultant, specialising in technology, strategy and operations, based out of Hong Kong. Since 2008, Al has been running CASP-R, a firm he founded to provide independent research and advisory services to investors and corporations, with a focus on real estate and technology. He is active in various Hong Kong-based angel investor groups that provide seed and growth funding to Asian-based tech and healthcare companies.